Dear Startup Investor, We have updates on two of our outstanding medical technology companies. They serve as chronological bookends. Medical Surgery Technologies, or MST, was one of our first recommendations from late 2013. And Reliant Immune Diagnostics was one of our most recent recommendations from earlier this year.
The markets are experiencing an artificial intelligence (AI) gold rush. There are at least 50 AI companies being incubated at Y Combinator. And new AI startups keep cropping…